Tele: 561.316.3330
Breaking Medical Device News

Monday, September 27, 2021
HomeEversanaMedRhythms and EVERSANA Announce Partnership: To Launch and Commercialize Chronic Stroke Software-based Medical Device

MedRhythms and EVERSANA Announce Partnership: To Launch and Commercialize Chronic Stroke Software-based Medical Device

MedRhythms, a Portland, Maine-based digital therapeutics company that is building direct stimulation, prescription digital therapeutics that use sensors, music, and software to improve walking impairments, announced today that it has initiated its partnership with EVERSANA™, a leading provider of global commercialization services to the life sciences industry, to launch and commercialize MR-001, its patented software-based medical device designed to treat chronic stroke walking deficits.

As previously announced, the product received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) in June 2020. Stroke is a leading cause of disability in the United States. More than half of stroke survivors, approximately 3.5 million people in the U.S., have persistent walking deficits. There is no standard of care for these long-term functional deficits, which negatively impact the lives of stroke survivors and their caregivers. This population is expected to grow with an increasing stroke survival rate and the aging population in the United States.

To support its anticipated launch, MedRhythms will utilize EVERSANA’s fully integrated commercialization services that include market access, agency services, clinical and commercial field teams, medical science liaisons, channel management, patient services, health economics and outcomes research, and compliance, with each service optimized by data and predictive analytics.

“Today’s announcement marks a significant milestone in our commitment to serve chronic stroke survivors who have waited lifetimes for a standard of care. After years of development and testing, we stand ready to successfully launch this groundbreaking innovation with a best-in-class commercialization partner,” said Owen McCarthy, President and Co-founder of MedRhythms.

“This breakthrough device demands a breakthrough, transformative approach to launch and commercialization,” said Jim Lang, Chief Executive Officer of EVERSANA. “We’re ready to deploy the full power of our infrastructure and experts to navigate the complexities of digital therapy launches to ensure this innovation quickly reaches the millions of chronic stroke patients desperately in need of treatment and a better quality of life.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Tyber Medical Reaches Agreement to Acquire CatapultMD

Once the acquisition is complete, Tyber Medical will own and operate a combined 100,000-square feet of manufacturing space between its Pennsylvania headquarters and Florida-based facilities.

Kleiner Device Labs Receives FDA Market Clearance for KG2 Surge Flow-Thru Interbody System

The system maximizes total bone graft delivery volume, better distributes graft bilaterally into the intervertebral disc space, and streamlines the implant delivery, positioning, and grafting process for TLIF and PLIF spinal fusion procedures.

Matthew Cranfill New ExtriCARE USA Director Of Clinical Services

"Matt's impressive experience and skillset easily made him our top pick," said Peter Mason, President of ExtriCARE USA.

FDA Authorizes Software that Can Help Identify Prostate Cancer

The software is called Paige Prostate and is compatible for use with slide images that have been digitized using a scanner.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

By using this website you agree to accept Medical Device News Magazine Privacy Policy